๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is a prospective, multi-center, single-arm, phase 2 study aiming to as...
Status
Recruiting
Location
Jun Feng Liu
Start Date
2022-05-01
Trial ID
NCT05241028
Treatments Being Tested
The main objective of this study is to evaluate the bioequivalency of two p...
Status
Completed
Location
Shanghai Public Health Clinical Center
Start Date
2018-06-11
Trial ID
NCT03536481
Treatments Being Tested
To assess treatment effectiveness and safety of oral X-396 capsule (Ensarti...
Status
Unknown
Location
Chest hospital affiliated to Shanghai jiao tong university
Start Date
2018-06-15
Trial ID
NCT03608007
Treatments Being Tested
To assess efficacy and safety of oral X-396 (Ensartinib) capsule in Chinese...
Status
Active Not Recruiting
Location
Cancer Hospital Chinese Academy Of Medical Sciences, Shenzhen Center
Start Date
2019-04-12
Trial ID
NCT03753685
Treatments Being Tested
To assess efficacy and safety of oral X-396 (Ensartinib) capsule in Chinese...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2019-03-21
Trial ID
NCT04415320
Treatments Being Tested
This is an open-label, Phase I single dose 2-part, crossover bioequivalence...
Status
Completed
Location
ICON - Early Development Services
Start Date
2022-11-29
Trial ID
NCT05665283
Treatments Being Tested
The main purpose of the study is to evaluate safety and efficacy of X-396(E...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-09-28
Trial ID
NCT03215693
Treatments Being Tested